SII enters into new partnership to accelerate manufacture, delivery of COVID-19 vaccines for India

Aug 07, 2020

New Delhi [India], Aug 7 : The Serum Institute of India (SII) has entered into a new landmark partnership with Gavi, the Vaccine Alliance...

SII announces strategic partnership with Biocon Biologics

Sep 17, 2021

New Delhi [India], September 17 : Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum...

Serum Institute of India resumes exports of COVID-19 vaccine under COVAX programme

Nov 26, 2021

Pune (Maharashtra) [India], November 26 : Serum Institute of India (SII) on Friday resumed the exports of its COVID-19 vaccine 'Covishield' to the international...

Multivalent meningococcal meningitis vaccine from SII achieves WHO prequalification

Jul 25, 2023

"As the first conjugate vaccine to safeguard against the five predominant causes of this deadly disease, MenFive® offers hope for a future free from...

SII launches India's first fully indigenously developed pneumococcal vaccine

Dec 28, 2020

Pune (Maharashtra) [India], December 28 : Serum Institute of India, the largest vaccine manufacturer in the world by doses, announces the launch of India's...

Afghanistan receives 468,000 doses of COVID-19 vaccine from India

Mar 09, 2021

Kabul [Afghanistan], March 9 : Afghanistan on Monday received 468,000 doses of COVID-19 vaccine 'Covishield' from the Serum Institute of India (SII).